Loading...

PTHS PELTHOS THERAPEUTICS INC Management Changes 8-K Filing

PLTH

PTHS

PELTHOS THERAPEUTICS INC

(PTHS)

2024 8-K

Show Summary

Summary

Healthcare Conference Update

Financial Results Update

Merger of Equals

Regulatory Compliance

Merger Agreement

Promissory Note

Corporate Merger

Corporate Merger

Annual Meeting Results

Stock Repurchase Plan

Convertible Note Financing ...

Appointment of CEO

Conference Presentation

External Links:

Chromocell Therapeutics Corp appoints Francis Knuettel II as Chief Executive Officer, effective March 13, 2024.

AI Assistant

PELTHOS THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.